GH vs PATH
Guardant Health Inc (GH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
GH currently screens at market cap $6.32B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the GH and PATH stock pages for the full models.
Not investment advice.